DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE
September 18-19, 2000
Slides
Accutane
September 18, 2000
Food and Drug Administration
Engineering a Risk Management Program
Accutane and Pregnancy Exposure
Hoffmann-La Roche Inc.
Introduction, Russell Ellison, MD, Roche Laboratories, Inc ppt
Benefits of Accutane, Guy F Webster MD, PhD, Jefferson Medical College ppt html
Accutane Use and Epidemiology, John E La Flore, MD, MSPH, Hoffmann-La Roche Inc ppt
An Assessment of the Accutane (Isotretinoin) Pregnancy Prevention Program, Allena A Mitchell, MD, Carla Van Bennekom, RN, MPH, Carol Louik, ScD, Boston University School of Public Health ppt
Targeted Pregnancy Prevention Program for Women on Accutane (Isotretinoin), Eileen Enny Leach MPH ppt
Risk Management Options, Russell Ellison, MD, Roche Laboratories, Inc ppt